October 28, 2013 / 1:10 PM / 4 years ago

Edwards Lifesciences earnings rise

1 Min Read

Oct 28 (Reuters) - Edwards Lifesciences Corp on Monday reported higher third-quarter earnings on strong sales of its artificial heart valves that are implanted without major invasive surgery.

Third-quarter net income was $77 million, or 68 cents per share, compared with $69 million, or 58 cents per share, a year earlier.

Analysts on average had expected 66 cents per share, according to Thomson Reuters I/B/E/S.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below